These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 20590636)
1. The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels. Singh A; Hildebrand ME; Garcia E; Snutch TP Br J Pharmacol; 2010 Jul; 160(6):1464-75. PubMed ID: 20590636 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of SKF96365 on the activities of K(+) channels in mouse small intestinal smooth muscle cells. Tanahashi Y; Wang B; Murakami Y; Unno T; Matsuyama H; Nagano H; Komori S J Vet Med Sci; 2016 Feb; 78(2):203-11. PubMed ID: 26498720 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of recombinant low-voltage-activated Ca(2+) channels by the neuroprotective agent BW619C89 (Sipatrigine). McNaughton NC; Hainsworth AH; Green PJ; Randall AD Neuropharmacology; 2000 Apr; 39(7):1247-53. PubMed ID: 10760366 [TBL] [Abstract][Full Text] [Related]
6. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels. Shcheglovitov A; Zhelay T; Vitko Y; Osipenko V; Perez-Reyes E; Kostyuk P; Shuba Y Biochem Pharmacol; 2005 Mar; 69(5):841-54. PubMed ID: 15710361 [TBL] [Abstract][Full Text] [Related]
7. SKF-96365 strongly inhibits voltage-gated sodium current in rat ventricular myocytes. Chen KH; Liu H; Yang L; Jin MW; Li GR Pflugers Arch; 2015 Jun; 467(6):1227-36. PubMed ID: 25017106 [TBL] [Abstract][Full Text] [Related]
8. Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches. Xie X; Van Deusen AL; Vitko I; Babu DA; Davies LA; Huynh N; Cheng H; Yang N; Barrett PQ; Perez-Reyes E Assay Drug Dev Technol; 2007 Apr; 5(2):191-203. PubMed ID: 17477828 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of recombinant low-voltage activated calcium channels. Lacinová L Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):105-11. PubMed ID: 15078185 [TBL] [Abstract][Full Text] [Related]
10. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels. Sidach SS; Mintz IM J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142 [TBL] [Abstract][Full Text] [Related]